← Back to Patent Explorer
US4230705A Expired / Lapsed US ⏱️ 0.0 years remaining

6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety

Assignee: Wyeth Holdings LLC
•
Filing: 1976-09-22
•
Granted: 1980-10-28
•
Expires: 1996-09-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This disclosure describes novel substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines useful as anxiolytic agents.

Inventors

  • 👤 George R. Allen, Jr.
  • 👤 John W. Hanifin, Jr.
  • 👤 Daniel B. Moran
  • 👤 Jay D. Albright

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 20:14
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/04; C07D295/14; C07D295/145; C07D237/00; C07D237/02; C07D237/04; C07D237/06; C07D237/08; C07D237/10; C07D237/12; C07D237/14; C07D237/20; C07D487/00; C07D487/02; C07D487/04

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 110 words
The method of meliorating anxiety in a mammal which comprises administering internally to said mammal an effective amount of a compound selected from the group consisting of those of the formula: ##STR3## wherein R 1 , R 2 , and R 3 are each individually selected from the group consisting of hydrogen and alkyl having up to four carbon atoms with the first proviso that when R 1 and R 2 are both hydrogen then R 3 may not be methyl and with the second proviso that when R 2 and R 3 are both methyl then R 1 may not be hydrogen; and the pharmacologically acceptable acid-addition salts thereof.
Claim 2
Independent Claim 110 words
The method of meliorating anxiety in a mammal which comprises administering internally to said mammal an effective amount of a compound selected from the group consisting of those of the formula: ##STR3## wherein R 1 , R 2 , and R 3 are each individually selected from the group consisting of hydrogen and alkyl having up to four carbon atoms with the first proviso that when R 1 and R 2 are both hydrogen then R 3 may not be methyl and with the second proviso that when R 2 and R 3 are both methyl then R 1 may not be hydrogen; and the pharmacologically acceptable acid-addition salts thereof.
Claim 3
Dependent Claim 130 words
A therapeutic composition in dosage unit form useful for meliorating anxiety in mammals comprising from about 0.03 milligram to about 10.0 milligrams per kilogram of body weight per daily dosage unit, in association with a pharmaceutical carrier, of a compound selected from the group consisting of those of the formula: ##STR4## wherein R 1 , R 2 , and R 3 l are each individually selected from the group consisting of hydrogen and alkyl having up to four carbon atoms with the first proviso that when R 1 and R 2 are both hydrogen then R 3 may not be methyl and with the second proviso that when R 2 and R 3 are both methyl then R 1 may not be hydrogen; and the pharmacologically acceptable acid-addition salts thereof.
Claim 4
Dependent Claim 130 words
A therapeutic composition in dosage unit form useful for meliorating anxiety in mammals comprising from about 0.03 milligram to about 10.0 milligrams per kilogram of body weight per daily dosage unit, in association with a pharmaceutical carrier, of a compound selected from the group consisting of those of the formula: ##STR4## wherein R 1 , R 2 , and R 3 l are each individually selected from the group consisting of hydrogen and alkyl having up to four carbon atoms with the first proviso that when R 1 and R 2 are both hydrogen then R 3 may not be methyl and with the second proviso that when R 2 and R 3 are both methyl then R 1 may not be hydrogen; and the pharmacologically acceptable acid-addition salts thereof.

References Cited (Backward Citations)

GB1187281A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-10-28 1984-04-28 1984-10-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-10-28 1988-04-28 1988-10-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-10-28 1992-04-28 1992-10-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag